CJC 1295 DAC Research Overview
CJC 1295 DAC is a growth hormone releasing hormone (GHRH) analogue peptide designed for in-vitro laboratory investigations. This synthetic 29-amino acid sequence represents a modified version of natural GHRH(1-29) with strategic amino acid substitutions at positions 2, 8, 15, and 27. The Drug Affinity Complex (DAC) component extends the peptide’s research window through albumin binding properties. Researchers at Stroid UK Shop utilise this compound to examine growth hormone axis modulation in controlled laboratory environments.
Laboratory Applications
This peptide serves as a valuable research tool for investigating GHRH receptor interactions and downstream signalling pathways. The DAC modification allows scientists to study prolonged receptor binding patterns compared to native GHRH sequences. Research teams examine its effects on growth hormone secretion profiles in cellular and tissue models. The compound’s extended half-life characteristics make it particularly useful for investigating sustained growth hormone release mechanisms. Studies focus on understanding pituitary somatotroph cell responses and growth hormone pulse patterns. Researchers from our CJC 1295 peptide collection investigate its comparative activity against standard growth hormone releasing compounds.
Research Specifications
| Chemical Name | CJC-1295 with Drug Affinity Complex |
|---|---|
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Sequence Length | 29 amino acids |
| Storage Temperature | -20°C (lyophilised) |
| Reconstitution | Bacteriostatic water |
| Stability | 2-8°C after reconstitution |
Scientists studying growth hormone physiology often compare this compound with other research peptides from our peptides category and complementary compounds in our SARMs collection. The peptide’s unique pharmacokinetic profile enables researchers to investigate extended-release growth hormone secretion patterns that differ significantly from immediate-release formulations.
Research Compliance
CJC 1295 DAC is strictly intended for in-vitro research purposes only. This product is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate safety protocols and regulatory compliance when handling this research peptide.
